tbuckley/cabot-search huggingface dataset:
Modernizing Rounds
Authors: Jason Stein, Susan Shapiro
Journal: Annals of Internal Medicine (2018)

Letters19 June 2018Modernizing RoundsJason Stein, MD and Susan Shapiro, PhD, RNJason Stein, MD1Unit, Atlanta, Georgia (J.S.) and Susan Shapiro, PhD, RNNell Hodgson Woodruff School of Nursing at Emory University, Atlanta, Georgia (S.S.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L18-0144 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Mossad raises an important question about integrating consulting physicians in interdisciplinary rounds and accurately enumerates reasons why physical integration is usually impractical. Here, we offer additional considerations.First, consistent start times and structure are critical to the success of interdisciplinary rounds and therefore must be driven by the synchronized workflows of unit-based physicians and staff.Second, if specialists lack training and practice in interdisciplinary rounds, they may adversely affect efficiency and effectiveness.Finally, integrating the inputs of specialists rather than the specialists themselves is often sufficient.The most viable approach is to treat the inputs of consulting ... Author, Article, and Disclosure InformationAffiliations: 1Unit, Atlanta, Georgia (J.S.)Nell Hodgson Woodruff School of Nursing at Emory University, Atlanta, Georgia (S.S.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-3334. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAnnals for Hospitalists Inpatient Notes - Modernizing Rounds—Why It's Time to Redesign Our Hospital Practice Jason Stein and Susan Shapiro Modernizing Rounds Sherif B. Mossad Metrics Cited byRedesigning the Clinical Learning Environment to Improve Interprofessional Care and Education: Multi-Method Program Evaluation of the iPACE Pilot Unit 19 June 2018Volume 168, Issue 12Page: 903-904KeywordsDisclosureElectronic medical records ePublished: 19 June 2018 Issue Published: 19 June 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Diabetic Ketoacidosis
Authors: Philip Felig
Journal: New England Journal of Medicine (1974)

BEFORE the availability of insulin, diabetic ketoacidosis was a uniformly fatal catastrophe. In the 50 years since insulin treatment has been employed, a progressive decline in mortality has been achieved to current levels of 3 to 10 per cent.1 Despite the marked improvement in success rate, considerable controversy still exists over the optimal mode of treatment. Recommendations differ about "large" versus "small" doses of insulin, the use of isotonic saline rather than hypotonic solutions, and the need for bicarbonate administration. Two basic principles are applicable to any therapeutic approach: successful treatment depends in large measure on individualization of therapy rather . . .
CONGENITAL STEATORRHEA
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence
Authors: J. J. Sorokin
Journal: JAMA (1974)

A prospective study of 102 patients who had undergone potentially curative operations for colorectal cancer was undertaken to correlate serial carcinoembryonic antigen (CEA) levels with the clinical course. When included in this study, patients selected had no detectable metastatic or recurrent disease. Twelve patients developed sustained elevations in their CEA levels greater than 2.5 ng/ml. Six of these had progressively rising CEA titers, and all developed subsequently recurrent cancer; rising CEA levels were observed 0 to 29 months before cancer recurrence was clinically detected. The six with "stable" elevations and six with transient elevations developed no clinically detectable cancer. Eighty-four patients with CEA levels consistently under 2.5 ng/ml had no evidence of recurrent neoplasms. Two developed second primaries. Serial CEA assays postoperatively help detect recurrent colon cancer in asymptomatic patients. (<i>JAMA</i>228:49-53, 1974)
Testosterone deficiency as a risk factor of coronary artery disease in postmenopausal women Agnieszka D. Kaczmarek, Krzysztof Reczuch, Katarzyna Sosnik, Jacek Majda, Waldemar Banasiak, Piotr Ponikowski. Military Hospital, Wroclaw, Poland
Journal: Journal of the American College of Cardiology (2001)
Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
Journal: New England Journal of Medicine (1997)

Correction from The New England Journal of Medicine — Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
Psychiatric Comorbidity in Pathological Gamblers Seeking Treatment
Authors: A. Ibanez
Journal: American Journal of Psychiatry (2001)

OBJECTIVE: The authors’ goal was to determine the frequency of psychiatric comorbidity among treatment-seeking pathological gamblers, compare the severity of gambling and psychological problems in gamblers with and without comorbid disorders, and investigate differences between gamblers with and without comorbid disorders in the dopamine D2 receptor gene (DRD2). METHOD: Sixty-nine pathological gamblers who consecutively applied to a specialized outpatient treatment program were evaluated with structured interviews, self-report questionnaires, and psychological scales and were genotyped for a DRD2 polymorphism. RESULTS: A comorbid psychiatric disorder was present in 43 (62.3%) of the gamblers. The most frequent diagnoses were personality disorders (N=29 [42.0%]), alcohol abuse or dependence (N=23 [33.3%]), and adjustment disorders (N=12 [17.4%]). Gamblers with comorbid psychiatric disorders had gambling scores and psychological scale scores indicating greater severity of gambling and psychopathology. Significant differences in DRD2 allele distribution were found in gamblers with and without comorbid disorders. CONCLUSIONS: Psychiatric comorbidity is common among pathological gamblers and is associated with greater severity of clinical problems. The DRD2 gene could be a liability genetic factor for psychiatric comorbidity in pathological gambling.
A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia &amp; Lymphoma (TACL) Study
Authors: Todd Michael Cooper, Jemily Malvar, Jeannette Cassar, Elena Eckroth, Richard Sposto, Paul Gaynon, Steven Dubois, Lia Gore, Margaret E. Macy, Keith J. August, Blythe Thomson, Javier Oesterheld, Guy Gammon, Daniel Magoon, Colleen E. Annesley, Patrick Brown
Journal: Blood (2013)
Quality of Care in Medicaid Managed Care vs Commercial Managed Care Plans
Authors: Stephen Somers, Richard J Baron
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE ANTITOXIN PRODUCTION.
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TOXICOLOGY AND MEDICAL JURISPRUDENCE.
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thyroid hormone treatment: new insights into an old therapy
Authors: D. S. Cooper
Journal: JAMA (1989)

Thyroid hormone preparations are among the most commonly prescribed medications in this country: in 1986, an estimated 20 million prescriptions were written for various forms of thyroid supplementation. Thyroid hormone formulations and the indications for thyroid hormone therapy have changed dramatically over the years, reflecting refinements in the understanding of thyroid physiology and thyroid hormone pharmacology. These changes have contributed to the bewildering array of thyroid hormone preparations that are available to the practitioner, as well as uncertainty about the proper therapeutic use of thyroid hormone. Thyroid hormone preparations can be classified into two broad categories: synthetic and biologic. Synthetic thyroxine (T<sub>4</sub>) is the preferred form of thyroid hormone for almost all therapeutic indications. Because of its 1-week half-life, thyroxine yields relatively stable blood levels, with only minimal daily fluctuations in serum T<sub>4</sub>concentrations. Furthermore, since peripheral tissues generate triiodothyronine (T<sub>3</sub>) from circulating T<sub>4</sub>, a preparation
Constitution and Health
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IMMUNITY IN TUBERCULOSIS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Index to volume 53
Authors: C Brtt('e, P Fili- I'owski, C Burek, W Bi~sse, A Johnson, Abst Johnson, Abst Johnstone, D ' Ro~hmann, Hahn 261 ' ' Jones, R S~~'glei~h, D Jose, Abst Kaliner, H Guirgis, K Karakitsos
Journal: Journal of Allergy and Clinical Immunology (1974)
After the Fall
Authors: Ted McMahon
Journal: JAMA (2013)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Quekett and microscopy.
Journal: BMJ (1965)

question of 1938 is to be found in the report by J. da Silva Horta and his colleagues" of Lisbon.They have traced as many as possible of 2,377 patients in Portugal in whom Thorotrast was used between 1930 and 1952.Adequate information was obtainable about 1,107, of whom 699 had died and 408 were still living at the end of 1963.Death had been due in 22 patients to haemangioendothelioma of the liver, a tumour almost unknown except from this cause.Fibrosis of the liver occurred in 42, and as a cause of death in 17.Leukaemia or aplastic anaemia developed in 16.A granuloma at the -site of injection occurred in 81 patients, causing death in 8 and being complicated by malignancy in 3. Malignant tumours at various other sites occurred in 22.The latent periods between administration of Thorotrast and the development of these conditions were about 5 years for granulomas, 15 for liver fibrosis, and 20 for liver tumours and leukaemias, although a few occurred much earlier.The authors admit that without comparison with a matched population, and without other information not available in Portugal, some of these findings are not conclusive, but the frequency of blood diseases is clearly excessive and the relation between cause and effect in the unique liver tumours is indisputable.They conclude that Thorotrast should never be administered to patients with a life expectation of more than two years.
Laboratory data
Authors: B. E. Copeland
Journal: JAMA (1968)

<h3>To the Editor:—</h3> During 1967 information with respect to medical laboratories was repeatedly presented to Congress by the Department of Health, Education, and Welfare which was a confused and sometimes inappropriate application of data from very limited surveys, mostly from Public Health Laboratories, including Indian Bureau and Federal Prison hospitals. The results of such surveys were assumed to apply to all hospitals in the United States. The conclusions drawn for the congressmen and senators were that 20 million tests per year are erroneous and that $470 million is being wasted yearly. These conclusions and the data (or lack of it) upon which they were based have been carefully reviewed and a detailed report has been published in the Congressional Record for Dec 14, 1967, (H.16075-78). Included in this report are facts which show, for example, that clinical chemistry tests are being judged by surveys conducted in the United States 15
YELLOW FEVER IN THE OLDEN TIME.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
When does diabetes start?
Authors: C. D. Saudek
Journal: JAMA (1990)

Diabetes causes multiple metabolic defects, and its complications attack multiple organ systems. But it is frustratingly difficult to pin down a specific link between these metabolic derangements and long-term complications. The venerable "control and complications controversy" persists because we keep looking for one answer, one simple relationship between glycemic control and diabetic complications. But why should the relationship be simple or linear? Why should the product of blood glucose and time necessarily cause, equally, such diverse end-organ damage as neuropathy, nephropathy, retinopathy, and accelerated atherosclerosis? Factors other than blood glucose are almost certainly involved. It should not be surprising, then, that obesity, blood pressure, high serum lipid levels, and family history play a significant role in macrovascular complications. Coexisting risk factors are especially relevant in type II, non—insulin-dependent diabetes, because this disease confers the most risk for accelerated atherosclerosis and the risk is most difficult to correlate specifically with glycemia.
MALARIA.
Authors: ELLSWORTH D. WHITING
Journal: JAMA (1896)

Malaria, or paludism, is a non-contagious, infectious disease, characterized by typical paroxysms, the principal pathologic changes being in the blood, liver and spleen. Its etiologic factor is a specific protozoon, the plasmodium malariæ of Laveran, which can generally be demonstrated in the red blood corpuscle. Malaria may be considered a primitive disease, that is, one found in newly settled countries. It attacks the settler when he turns the soil for the first time, when there is no drainage and when the shallow wells fill from the surface. As soon as the swamps are drained and the wells freed from surface water the "chills and fever" disappear. As to the geographic distribution of malaria, it is quite extensive, being found in tropical, subtropical and temperate zones. In the northern part of Africa malaria is endemic. It was there that Laveran made his first discoveries. In Europe, southern Russia and Italy are